FDA Approved: EMTRICITABINE — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Emtricitabine submitted by Cipla USA Inc., updating the approved labeling for the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Viral Hepatitis

Drugs mentioned

• Emtricitabine (Emtricitabine)

Snippet

SUPPL AP for EMTRICITABINE (EMTRICITABINE)